Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyperHDL2 cholesterolemia with abnormal cholesteryl ester transfer-Reference-Cited by-同舟云学术

Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyperHDL2 cholesterolemia with abnormal cholesteryl ester transfer

Published:1988-07 Issue:3 Volume:62 Page:B66-B72
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Matsuzawa Yuji,Yamashita Shizuya,Funahashi Tohru,Yamamoto Akira,Tarui Seiichiro

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. Plasma high density lipoprotein concentration and development of ischemic heart disease;Miller;Lancet,1975

2. Summary estimates of cholesterol used to predict coronary heart disease;Castelli;Circulation,1983

3. Coronary artery disease in heterozygous familial hypercholesterolemia;Hirobe;Atherosclerosis,1982

4. Effects of probucol on homozygous cases of familial hypercholesterolemia;Yamamoto;Atherosclerosis,1983

5. Studies on the mechanism of regression of lipid storage in familial hypercholesterolemia;Matsuzawa,1985

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Coronary Heart Disease (PROSPECTIVE);Journal of Atherosclerosis and Thrombosis;2021-02-01

2. New Horizons for Probucol, an Old, Mysterious Drug;Journal of Atherosclerosis and Thrombosis;2021-02-01

3. Recent advances in synthetic pharmacotherapies for dyslipidaemias;European Journal of Preventive Cardiology;2019-05-06

4. Shotgun proteomic analysis reveals proteome alterations in HDL of patients with cholesteryl ester transfer protein deficiency;Journal of Clinical Lipidology;2019-03

5. Cholesteryl ester transfer protein: An enigmatic pharmacology – Antagonists and agonists;Atherosclerosis;2018-11